Japanese private equity firm New Horizon Capital has acquired 100% of Kagayaku Cosmetics from Ant Capital Partners for an undisclosed sum.
Affinity Equity Partners has begun a process to exit its 35% interest in the frequent flyer business of Virgin Australia.
Southeast Asia’s internal growth and rising appeal among global investors in recent years have fed expectations that PE and VC exits will follow. The logic is sturdy but detailed projections are elusive
India has skirted around an expected boom in secondaries activity for the past couple of years, but investors haven’t lost faith in the narrative’s eventual unfolding. The devil will be in the details
NAB Ventures, a unit of National Australia Bank (NAB), is set for its debut exit via a deal that will see US tax services giant H&R Block acquire Canada’s Wave Financial for about $400 million.
Malaysian government-backed private equity firm Ekuinas has exited its entire majority holdings in local healthcare players MediExpress and PMCare to Japan’s Sumitomo Corporation.
Chinese online brokerage Tiger Brokers, which is backed by smart phone maker Xiaomi and a number of venture capital firms, has filed for an IPO in the US.
Corsair Capital has agreed to exit most of its controlling stake in DP World Australia to the shipping services provider’s original corporate parent.
Korea comes to the fore as investment in China slows; venture capital and pan-regional players remain preeminent in Asia fundraising; IPO weakness reflects investor wariness
Private equity investment in Asia slowed to $183.3 billion in 2018 – from $207.3 billion the previous year – as a decline in large-scale buyout activity offset a surge in late-stage rounds for technology companies.
SunBridge Partners, a US-based VC firm that helps companies access Japan, has exited its position in a Japanese joint venture (JV) with B2B cloud technology provider Marketo to Adobe.
Futu Securities International, a Hong Kong-based online brokerage backed by Sequoia Capital China and Matrix Partners China, has filed to list in the US.
PE-backed WuXi AppTec, a contract pharmaceutical R&D services provider, traded flat on its Hong Kong debut, following an IPO of HK$9.1 billion ($1.1) billion.
Paddy Sinha, a managing partner with Tata Opportunities Fund, discusses macroeconomic and policy developments in India, the availability of buyouts, and the outlook for exits
Tongcheng-Elong, a Chinese online travel services company backed by Tencent Holdings, Ctrip and local PE player Ocean Link, surged on its Hong Kong trading debut following a HK$1.62 billion ($207 million) IPO.
VCs face new challenges and opportunities in exit markets across Asia as later-stage investors and strategic players participate more deeply in early-stage ecosystems.
Bain Capital completed a hattrick of wins at the 2018 AVCJ Private Equity & Venture Capital Awards, securing the prizes for firm of the year, deal of the year, and exit of the year – each one in the large-cap category. Quadrant Private Equity was named...
L Catterton Asia has made a partial exit from Chinese mall operator Sasseur citing ongoing efforts to optimize its portfolio.
New Zealand’s Direct Capital has exited its remaining 13.7% stake in domestic carpet manufacturing industry services provider Cavalier Wool Holdings (CWH) for an undisclosed sum.
Nominations for the 2018 AVCJ Private Equity & Venture Capital Awards have now closed. The public voting stage of the process will begin around October 10.
Warburg Pincus has acquired Chinese mother-and-baby company Leyou, providing an exit for CDIB Capital and The Carlyle Group. The deal signals a rapid maturation process in the segment
Warburg Pincus has agreed to acquire a majority stake in Chinese maternity products supplier Leyou. The deal will facilitate exits for The Carlyle Group and CDIB Capital.
Vietnam-based Mekong Capital has exited its stake in Asia Chemical Corporation (ACC), a domestic industrial supplier, for $8.9 million, generating a gross return multiple of 2.6x and a gross IRR of 15.1%.
TPG Capital has acquired a significant minority stake in Indian drug developer and manufacturer Sai Life Sciences, providing a full exit for Tata Capital Growth Fund.